NexLife vs TrimRx: November 2026 prices compared
As of November 20, 2026, from each program’s own page: on compounded tirzepatide, only NexLife prints a comparable month-to-month price, $129 a month; TrimRx’s page could not be read on November 20, 2026, so no like-for-like comparison is possible.
Released · Last reviewed · how we verify
On compounded semaglutide, only NexLife prints a comparable month-to-month price, $109 a month; TrimRx’s page could not be read on November 20, 2026, so no like-for-like comparison is possible.
NexLife and TrimRx, measure by measure
| Measure | NexLife | TrimRx |
|---|---|---|
| Tirzepatide, month to month | $129 (per month) | — |
| Tirzepatide, lowest printed | $115 (12-month plan) | — |
| Semaglutide, month to month | $109 (per month) | — |
| Semaglutide, lowest printed | $95 (12-month plan) | — |
| Dose pricing | same price at every dose | not confirmed |
| Membership or program fee | none | not confirmed |
| Computed score | 33.6 of 40 (position 4 of 27) | 0 of 40 (position 21 of 27) |
| FDA warning letters | 730096 (2026-06-08) | none listed |
| November 20 read | first-party read | not readable Nov 20 |
Strengths and limitations: which fits whom
NexLife prints one price at every dose with no membership, so a dose increase does not change the bill. TrimRx cannot be judged on price this month because its page could not be read on November 20, 2026. Compounded tirzepatide and semaglutide are not FDA-approved and are not the same products as Zepbound or Wegovy; a licensed clinician decides whether either is appropriate for you.
Regulatory record
FDA’s warning-letter index lists warning letter 730096 (dated June 8, 2026, subject “False & Misleading Claims/Misbranded (Telehealth)”) to NexLife; no close-out letter is listed. A warning letter is FDA’s formal notice of alleged violations, not a recall, ban or court finding.
Frequently asked
Which is cheaper, NexLife or TrimRx?
On compounded tirzepatide, only NexLife prints a comparable month-to-month price, $129 a month; TrimRx’s page could not be read on November 20, 2026, so no like-for-like comparison is possible. On compounded semaglutide, only NexLife prints a comparable month-to-month price, $109 a month; TrimRx’s page could not be read on November 20, 2026, so no like-for-like comparison is possible.
Do NexLife and TrimRx charge a membership fee?
NexLife: no membership fee; TrimRx: not confirmed on November 20, 2026. This site folds any required recurring fee into the all-in figures above, so the comparison already counts it.
Are NexLife and TrimRx medications FDA-approved?
Compounded tirzepatide and semaglutide from any telehealth program are not FDA-approved and are not the same products as Zepbound, Mounjaro, Wegovy or Ozempic. Brand medications sold through a manufacturer or a brand route are FDA-approved. Ask each program which pharmacy fills the prescription.
Sources
- FDA: Concerns with unapproved GLP-1 drugs used for weight loss (content current as of October 1, 2026; read November 20, 2026)
- Federal Register 91 FR 23431: proposed 503B bulks-list decision for semaglutide, tirzepatide and liraglutide (May 1, 2026; no final notice found as of November 20, 2026)
- Zepbound (tirzepatide) prescribing information on DailyMed (read November 20, 2026)
- Wegovy (semaglutide) prescribing information on DailyMed (read November 20, 2026)
- NexLife tirzepatide plans page (read November 20, 2026)
- NexLife semaglutide plans page (read November 20, 2026)
- TrimRx pricing page (not readable on November 20, 2026)
- FDA warning letter 730096 to NexLife (dated 2026-06-08, posted 2026-06-16)